In a new job - March 2, 2023
Immunovia appoints new COO
Immunovia has announced the appointment of Karl Stone as Chief Operating Officer effective 1 March, 2023. Immunovia has added a new Chief Operating Officer role to its executive team to align with strategic priorities and focus on the US commercialization of the IMMray PanCan-d test, it states. The Chief Operating Officer will be responsible for […]
In a new job - March 1, 2023
She is the new CMO at Medivir
The company’s new Chief Medical Officer (CMO) is Pia Baumann. As member of the company’s management team her responsibilities include the continued clinical development of the candidate drug fostroxacitabine bralpamide (fostrox), states the company. “I am very pleased that Pia now has taken up the role as Chief Medical Officer. She is joining us at […]
In a new job - March 1, 2023
She is the new Chief Technology Officer at Alligator
Alligator Bioscience has announced the promotion of Laura von Schantz to Chief Technology Officer, and her joining the executive management team. In this role, she will oversee all technical aspects in the development of Alligator’s preclinical and clinical pipeline, including lead assets mitazalimab, a CD40 agonist currently in Phase 2 clinical development, and ATOR-1017, a […]
In a new job - February 25, 2023
BCB Medical appoints new CEO
Marcus Kaber was appointed Chief Executive Officer of the company on February 1. “We are excited to have Marcus as a part of our executive team. Our leadership team has vast knowledge of the pharmaceutical and medical industries, while Marcus brings a track record and experience in how to build successful software companies in an […]
In a new job - February 23, 2023
Changes to Sobi’s management
Tony Hoos to replace Anders Ullman as Head of R&D and Medical Affairs and Chief Medical Officer from 1 April 2023. Anton (Tony) Hoos, M.D., Ph.D., MBA will become Head of R&D and Medical Affairs and Chief Medical Officer and replace Anders Ullman, M.D., Ph.D. who will retire. Tony Hoos Dr Hoos brings more than […]
Biotech Business - February 21, 2023
IRLAB changes CEO and appoints new Chairman
IRLAB Therapeutics has announced that its CEO Richard Godfrey is leaving his position and that the Board of directors has appointed Gunnar Olsson as Interim CEO. This news follows the disappointing Phase IIb trial results of mesdopetam in people with Parkinson’s disease levodopa-induced dyskinesias (PD-LIDs), presented by the company just a few weeks ago. The primary endpoint, […]
